ACTO Newsletter is a periodic publication about Russian clinical trials market. As we currently foresee, regular sections in this Newsletter will provide an analysis of the dynamics of the clinical trials market and review of legislative initiatives and amendments as well as practical challenges and solutions. However, at the same time we would like the report to be up to speed with constant developments, which means that Newsletter’s structure and content may change in accordance with market demands.
The decision to commence publication of the Newsletter has been prompted primarily by the reorganization of the regulatory system after September 1, 2010 and its consequences to the pharmaceutical market. By creating the Newsletter ACTO not only carries out its charter purpose of assisting the development of the clinical trials market, but also reacts to the already formed public opinion. A demand for up-to-date information about the market situation, for a competent interpretation of such information and provision of recommendations on the part of Russian market players and foreign sponsors, has been evident for a long time.